The organisation and results of first screening round of the Hungarian nationwide organised breast cancer screening programme

Annals of Oncology

Volumn 18, Issue 4, 2007, Pages 795-799

  Boncz, Imre ^a,b   Sebestyen A ^c   Dobrossy L ^d   Pentek Z ^e   Budai, A ^d   Kovacs A ^d   Dozsa C ^f   Ember, I ^b  

^a National Health Insurance Fund Administration OEP   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c South Transdanubian Regional Health Insurance Fund Administration   (Hungary)

^d National Public Health and Medical Officers' Service   (Hungary)

^e MaMMa Healthcare Institute   (Hungary)

^f Ministry of Health   (Hungary)

Author keywords

Breast cancer; Breast neoplasms; Hungary; Mammography; Mass screening; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; DATA BASE; FEMALE; HEALTH PROGRAM; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

EID: 34047104031     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl489     Document Type: Article

References (27)

1. Tabar, L, Fagerberg CJ, Gad A et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829-832.
2. Shapiro S, Venet W, Strax P et al. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69: 349-355.
3. Bulliard JL, La Vecchia C, Levi F. Diverging trends in breast cancer mortality within Switzerland. Ann Oncol 2006; 17: 57-59.
4. Sasieni P. Evaluation of the UK breast screening programmes. Ann Oncol 2003; 14: 1206-1208.
5. Gabe R, Duffy SW. Evaluation of service screening mammography in practice: The impact on breast cancer mortality. Ann Oncol 2005; 16 (Suppl 2): 153-162.
6. Tyczynski JE, Plesko I, Aareleid T et al. Breast cancer mortality patterns and time trends in 10 new EU member states: Mortality declining in young women, but still increasing in the elderly. Int J Cancer 2004; 112: 1056-1064.
7. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.
8. Dobrossy L. Cancer mortality in central-eastern Europe: Facts behind the figures. Lancet Oncol 2002; 3: 374-381.
9. Boncz I, Sebestyen A, Dobrossy L et al. The attendance of the first screening round (2002-2003) of the Hungarian organised, nationwide breast cancer screening programme. Ann Oncol 2005; 16 (Suppl 2): 299-300 (Abstr 108P).
10. Boncz I. Organized nationwide breast cancer screening programme was introduced in Hungary in 2002 [Letter to the editor]. Swiss Med Wkly 2006; 136: 328.
11. Patnick J. NHS breast screening: The progression from one to two views. J Med Screen 2004; 11: 55-56.
12. Boncz I, Nagy J, Sebestyen A, Korosi L. Financing of health care services in Hungary. Eur J Health Econ 2004; 5: 252-258.
13. Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003; 12: 213-222.
14. Broeders MJ, Scharpantgen A, Ascunce N et al. Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000. Eur J Cancer Prev 2005; 14: 107-116.
15. Sarkeala T, Anttila A, Forsman H et al. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 2004; 40: 2116-2125.
16. The European community. European guidelines for quality assurance in mammography screening, Europe against cancer programme. Luxembourg: Office for Official Publications of the European Communities 2001.
17. Fracheboud J, de Koning HJ, Boer R et al. Nationwide breast cancer screening programme fully implemented in The Netherlands. Breast 2001; 10: 6-11.
18. Wang H, Karesen R, Hervik A. Thoresen SO. Mammography screening in Norway: Results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control 2001; 12: 39-45.
19. Hakama M, Elovainio L, Kajantie R, Louhivuori K. Breast cancer screening as public health policy in Finland. Br J Cancer 1991; 64: 962-964.
20. Nystrom L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography: Overview of Swedish randomized trials. Lancet 1993; 341: 973-978.
21. Bulliard JL, De Landtsheer JP, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer 2003; 39: 1761-1769.
22. Wait SH, Allemand HM. The French breast cancer screening programme. Epidemiological and economic results of the first round of screening. Eur J Public Health 1996; 6: 43-48.
23. Autier P, Shannoun F, Scharpantgen A et al. A breast cancer screening programme operating in a liberal health care system: The Luxembourg mammography programme 1992-1997. Int J Cancer 2002; 97: 828-832.
24. Duffy SW, Gabe R. What should the detection rates of cancers be in breast screening programmes? Br J Cancer 2005; 92: 597-600.
25. Governmental Statistical Service. Breast Screening Programme, England: 1999/ 2000. 2001. Bulletin 2001/10.
26. Barchielli A, Federico M, De Lisi V et al. In situ breast cancer: incidence trend and organised screening programmes in Italy. Eur J Cancer 2005; 41: 1045-1050.
27. European Commission. European guidelines for quality assurance in breast screening and diagnosis, 4th edition. Luxembourg: Office for Official Publications of the European Communities 2006.